Number of the records: 1  

syndróm neuroleptický malígny

  1. Record numberd009459
    Date06.06.2025
    TypeM
    Topical termsyndróm neuroleptický malígny
    Other termEnglish (Pseudonym) Neuroleptic-Induced Neuroleptic Malignant Syndrome
    English (Pseudonym) Neuroleptic-Malignant Syndrome, Neuroleptic Induced
    Slovak (Pseudonym) neuroleptikami indukovaný neuroleptický malígny syndróm
    Slovak (Pseudonym) neuroleptikami spôsobený neuroleptický malígny syndróm
    Slovak (Pseudonym) neuroleptikami vyvolaný neuroleptický malígny syndróm
    Slovak (Pseudonym) syndróm neurolepticko-malígny, indukovaný neuroleptikami
    Slovak (Pseudonym) syndróm neurolepticko-malígny, spôsobený neuroleptikami
    Slovak (Pseudonym) syndróm neurolepticko-malígny, vyvolaný neuroleptikami
    UDCC10.228.140.079.737C10.720.737C25.723.705.600
    NoteA potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.